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Abstract
Strategies to address undernutrition in low- and middle-income countries (LMICs) include various
interventions implemented through different sectors of the economy. Our aim is to provide an
overview of published economic evaluations of such interventions and to compare and contrast
evaluations of interventions in different areas. We reviewed economic evaluations of nutrition
interventions in LMICs published since 2015 and/or included in the Tufts Global registry or Disease
Control Priorities 3rd edition. We categorized the studies by intervention type (preventive; thera-
peutic; fortification; delivery platforms), nutritional deficiency addressed and characteristics of the
economic evaluation (e.g. type of model, costs and outcomes included). Of the 62 economic evalu-
ations identified, 56 (90%) were cost-effectiveness analyses. Twenty-two (36%) evaluations investi-
gated fortification and 23 (37%) preventive interventions. Forty-three percent of the evaluations of
preventive interventions did not include a model, whereas most of fortification strategies used the
same reference model. We identified different trends in cost categories and inclusion of health and
non-health outcomes across evaluations in the four different topic areas. To illustrate the implica-
tions of such trends for decision-making, we compared a set of studies evaluating alternative strat-
egies to combat zinc deficiency. We showed that the use of ‘off-the-shelf’ models and tools can po-
tentially conceal what outcomes and costs and value judgements are used. Comparing
interventions across different areas is fundamental to assist decision-makers in developing their
nutrition strategy. Systematic differences in the economic evaluations of interventions delivered
within and outside the health sector can undermine the ability to prioritize alternative nutrition
strategies.
Keywords: Decision-making, economic evaluation, systematic reviews, priority setting, cost-effectiveness analysis, cost–benefit
analysis, maternal and child health, nutrition
Introduction
Undernutrition relates to the inadequate intake of energy or vital
nutrients, which leads to ill health effects that manifest in: stunting (i.e.
low height-for-age); wasting (i.e. low weight-for-height); underweight
(i.e. low weight-for-age); and micronutrient-related deficiencies (i.e.
inadequacies in intake of vitamins and minerals) (WHO, 2018).
Undernutrition in children leads to an increased risk of death and has
been considered a leading cause of disability and ill health and has been
linked to poor mental development and school achievement as well as
behavioural abnormalities (Martins et al., 2011). Through its effects on
health, undernutrition increases healthcare costs, reduces productivity
and slows economic growth (WHO, 2017).
In low- and middle-income countries (LMICs), more than a
quarter of children under five (148 million) suffered from stunting
in 2018. In the same year, 48 million suffered from wasting, with
nearly 16 million cases of severe wasting (UNICEF, 2019; UNICEF
et al., 2019). The economic costs of undernutrition, in terms of lost
national productivity and economic growth, are equivalent to
11% of GDP in Africa and Asia each year (World Bank, 2019a).
Undernutrition is therefore an important public health problem and
remains a major challenge for the majority of the LMICs.
Evidence shows that timely intervention can prevent adverse
effects of undernutrition (Bhutta et al., 2008; Menon et al., 2018).
However, due to limited resources, it is not possible to fund every
VC The Author(s) 2020. Published by Oxford University Press in association with The London School of Hygiene and Tropical Medicine.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unre-
stricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. 1
Health Policy and Planning, 2020, 1–9
doi: 10.1093/heapol/czaa149
Review
effective intervention, and it is necessary to take decisions regarding
which course(s) of action to follow. For this reason, economic evalu-
ation (i.e. the comparative analysis of alternative courses of action
in terms of both their costs and consequences) becomes necessary
(Drummond et al., 2015).
A recent overview of systematic reviews of effectiveness (Salam
et al., 2015) categorized nutrition interventions into four umbrella
areas: preventive; therapeutic; fortification strategies; and delivery
platforms (Table 1). According to World Health Organization guide-
lines, these various approaches should be regarded as complementary,
with their relative importance depending on local conditions and the
specific mix of local needs. For example, programmes that deliver
micronutrient supplements often provide the fastest improvement in
the micronutrient status of individuals or targeted population groups.
Food fortification tends to have a less immediate but nevertheless a
much wider and more sustained impact (Allen et al., 2006). To assist
in the prioritization of the most valuable set of interventions, econom-
ic evaluations should ideally take a consistent approach to the charac-
terization of costs, effects and value for money.
The aim of this systematic review is to provide an overview of
economic evaluations of nutrition-specific interventions aimed at
tackling undernutrition in LMICs. We focus on a specific set of rec-
ommended nutrition-specific interventions and programmes (Black
et al., 2013; Bhutta et al., 2013; 2008) and compare and contrast
evaluations of interventions in different areas.
Methods
Search methods for identification of studies
In 2015, Disease Control Priorities (DCP) 3rd edition (Black et al.,
2016) published a review of cost-effectiveness studies on global
reproductive, maternal, newborn and child health that included nu-
trition interventions. In our review, we included all nutrition studies
reported in DCP, and the Tufts Global Health Cost-Effectiveness
Analysis database (Tufts Center for the Evaluation of Value and
Risk in Health). We adapted the DCP search strategy to identify
studies included in MEDLINE and Embase database from 2015 to
March 2019. Finally, we reviewed the reference lists of any system-
atic reviews we identified for additional studies. Search strategies
are reported in the Supplementary Material.
Study eligibility
The focus was restricted to full economic evaluations of nutrition-
specific interventions in low- and middle-income countries (World
Bank, 2019b). We defined nutrition-specific interventions and pro-
grammes, as in Black et al. (2013). We only included economic eval-
uations that directly looked at nutrition-related outcomes (Bhutta
et al., 2008; 2013). We excluded studies on other forms of malnutri-
tion (such as obesity and excess calorie intake) and economic evalua-
tions without a specific focus on the health impacts of inadequate
micronutrient or energy intake (e.g. cost-effectiveness analyses of
producing and delivering fortified food, or evaluations assessing
impacts on cognitive development outcomes only).
Data extraction and categorization
We assessed the quality of the eligible studies using the Consolidated
Health Economic Evaluation Reporting Standards guideline
(Husereau et al., 2013). For each study, if applicable, we rated each
item as ‘satisfied’, ‘partially satisfied’ or ‘not satisfied’. For each
study, we extracted information on the setting, target population,
type of intervention and comparator, type of economic evaluation,
KEY MESSAGES
• Strategies to address undernutrition in low- and middle-income countries include various interventions implemented through different
sectors of the economy. Comparing interventions across different areas is fundamental to assist decision-makers in developing a cost-
effective nutrition strategy.
• Due to different frameworks for economic evaluation and differences in the costs and outcomes included for interventions delivered
in different sectors, studies can be difficult to compare. For example, economic evaluations of interventions delivered within and out-
side the health system (e.g. nutritional supplements for malnutrition vs fortification of oil) often differ in the set of costs they include.
• The use of ‘off-the-shelf’ models and tools can conceal what outcomes, costs and value judgements are included in the economic
evaluation. Our study suggests to highlight these underlying components in economic evaluations to promote the consistency and
ease of interpretation.
Table 1 Categories adapted from Salam et al. (2015)
Topic area Description Examples
Preventive nutrition
interventions
Interventions to prevent undernutrition and
micronutrient deficiencies
Preventive zinc supplementation; breast feed-




Interventions to treat undernutrition and micro-
nutrient deficiencies
Ready-to-use therapeutic food for community
management of severe acute malnutrition;
therapeutic zinc supplementation; therapeut-
ic multiple micronutrient supplementation
Fortification strategies Deliberately increasing the content of an essen-
tial micronutrient in food to improve the nu-
tritional quality of the food supply
Single nutrient fortifications
Delivery platforms Specific modes and channels of delivering
interventions
Conditional cash transfers
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method for the estimation of the treatment effect, type of health and
non-health outcomes included, categories of costs considered and
presence and type of analytical model and summary results. A data
extraction form is included in the Supplementary Material. All
articles chosen for extraction were read by two reviewers and any
discrepancies were resolved by discussion with a third.
In this review, a distinction was drawn between impacts on pri-
vate consumption (e.g. out-of-pocket expenditures) and productiv-
ity. Productivity refers to the value of current and future goods and
services produced by an individual and includes both formal paid
production and informal production (e.g. domestic labour and car-
ing responsibilities). We included consumption incurred by individu-
als (i.e. due to purchases of goods in private markets) in the costs,
whereas impacts on productivity and ability to work (i.e. value of
goods and services produced by an individual) were considered as
non-health outcomes of the intervention.
We distinguished costs falling within and outside the health sys-
tem. The first group included costs incurred by the health system
and public expenditure in the health sector. With costs falling out-
side the health system, we distinguished those eligible for public
funding in other public sectors (e.g. agriculture, education), private
sector expenditure (e.g. costs of fortification programmes incurred
by food manufacturers) and out-of-pocket expenditure and house-
hold costs. We did not make any currency adjustment.
Some authors did not explicitly report the use of a decision
model; however, in their analysis, the risk of experiencing different
events was combined with specific costs and outcomes to obtain
results. For example, a given level of a nutrition deficiency (vitamin
A) was linked to a probability of ill health events (e.g. Bitot’s spots,
night blindness and blindness) to which were attached health-related
quality of life scores and costs. In other words, the economic evalu-
ation was implicitly based on a decision tree model with a probabil-
ity node leading to specific events, to whose specific costs and
outcomes were attached. We classified such analyses as economic
evaluations based on a decision tree model.
We categorized studies according to: types of intervention, types
of economic evaluation and perspectives on costs and outcomes.
Where a study included multiple economic evaluations of different
interventions or strategies belonging to multiple topic areas, the
evaluation was included in all relevant categories. To better illus-
trate the challenge of comparing across studies, we developed a case
study based on strategies to combat zinc deficiency in China.
Results
Search results
Data on numbers of records, abstracts read and articles that quali-
fied for data extraction are given in the flowchart in Figure 1.
The 54 studies identified by our review provided 62 separate eco-
nomic evaluations across 4 topic areas (4 studies reported economic
evaluations of interventions belonging to 2 different topic areas
each; 2 studies reported economic evaluations of interventions
belonging to 3 different topic areas). Detailed information about set-
ting, target population, type of intervention and comparator, type of
evaluation and main results of included economic evaluations is
found in Supplementary Table S1. Supplementary Table S2 summa-
rizes the main characteristics of identified economic evaluations:
method for the estimation of the treatment effect; type of health and
non-health outcomes included; categories of costs considered; and
presence and type of analytical model.
Types of intervention
Using the categories reported in Table 1, we characterized the inter-
ventions accordingly: 22 (36%) fortification strategies; 23 (37%)
preventive; 12 (19%) therapeutic; and 5 (8%) delivery platforms.
The fortification strategies comprised mainly (77%) fortification of
rice, oil, sugar or wheat to address specific nutritional deficiencies,
such as vitamin A, zinc, iron or folic acid deficiency; the reminder
addressed multiple deficiencies. Preventative interventions addressed
mainly (74%) specific nutritional deficiencies (i.e. vitamin A, zinc,
iron, calcium, energy/protein, vitamin K and folic acid). Three out
of four economic evaluations of therapeutic nutrition interventions
analysed community-based approaches to address generic malnutri-
tion and provide supplementary nutrition. Delivery platforms
Figure 1 PRISMA flow diagram
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included, e.g. price subsidies and franchising interventions to ad-
dress iron, zinc and other multiple deficiencies (Figure 2).
Types of economic evaluation
We identified 56 (90%) CEAs, 1 (2%) CEA and cost–benefit ana-
lysis (CBA) conducted in parallel, 4 (7%) CBAs and 1 (2%) social
return on investment (SROI). All CBAs and SROIs evaluated pre-
ventive interventions. Across all topic areas, 45 (73%) economic
evaluations included a decision model; 40 (65%) were based on a
decision tree and 4 (6%) on a Markov model; 1 analysis was based
on a combination of decision tree and Markov model; 2 evaluations
did not report enough information to assess whether a model was
used (Figure 3). Less than half (43%) of the economic evaluations of
preventive interventions did not include a model and more than one-
third (35%) were within-trial economic analyses (see Supplementary
Table S2 for further details). By contrast, all evaluations of fortifica-
tion strategies were based on a model, and the treatment effect esti-
mates used in the economic evaluations of fortification strategies
were usually (91%) based on previous literature or assumptions.
When a model was employed for the evaluation of preventive,
therapeutic and delivery interventions, this was typically original
(i.e. newly developed). Across these three topic areas, 24 evaluations
included a model, of which 16 (63%) were original model, with the
remainder using previous examples or tools (see Supplementary
Table S2 for further details). By contrast, all evaluations of fortifica-
tion strategies were based on a model, and 17 out of 21 (81%) were
based on a previously developed model. Of note, 15 evaluations
were based on various versions of the Harvest-Plus approach, which
is designed to measure costs and health benefits of biofortified staple
crops (Zimmermann and Qaim, 2004; Stein et al., 2005).
Quality assessment
On average, studies reported that 85% of the items included in the
checklist. However, in 31 studies (57%), the perspective was not ex-
plicitly specified and its impact on costs was not discussed. Of note,
Figure 2 Deficiencies addressed. Total number of economic evaluations (82) is higher than the total number of studies (54) because some studies included inter-
ventions that address various deficiencies and were therefore included in all relevant categories
Figure 3 Type of decision model by topic area. Total number of economic
evaluations (62) is higher than the total number of studies (54) because some
studies conducted economic evaluations of multiple interventions belonging
to different areas
Figure 4 Health and non-health costs and outcomes
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the perspective item was reported in only 22% and 23% of the eco-
nomic evaluations of preventive and fortification strategies, respect-
ively. By contrast, the same element was reported in 75% and 80%
of the economic evaluations of therapeutic interventions and deliv-
ery platform, respectively. Furthermore, out of 39 studies based on a
model, 12 (31%) did not explain the choice of model and 10 (26%)
did not describe and give adequate reasons for the specific type of
decision analytical model used. Of note, model choice item was not
satisfied in 42% and 32% of the economic evaluations of preventive
and fortification strategies, respectively. By contrast, all economic
evaluations of delivery platform and 78% of therapeutic interven-
tions reported the model choice item. The complete report of the
quality assessment is reported in Supplementary Table S3.
Perspectives on costs and outcomes
We grouped the studies according to the components included in the
primary result of the economic evaluation (i.e. type of outcome and
costs categories that compose the incremental cost per outcome for
CEAs; costs and benefits included in the cost–benefit ratio and re-
turn on investment for CBAs and SROIs, respectively). Overall,
studies measured a great variety of health outcomes including mor-
tality, years of life lost, generic health outcomes (such as DALYs
and QALYs), nutrition-related disease-specific outcomes (such as
anaemia, Bitot’s spots, night blindness, corneal scarring, blindness,
diarrhoea, neural tube defects), monetary values and disease-specific
outcomes not directly linked to undernutrition (e.g. malaria, HIV
infections).
Six economic evaluations (10%) considered only costs falling
within the health system. These were all analyses of preventive and
therapeutic interventions. Of these, 5 (83%) considered only health
outcomes (i.e. DALYs and/or other specific health outcomes); the
remaining study included also non-health outcomes (productivity
and education). Twenty-four economic evaluations (39%) consid-
ered only costs falling outside the health system. Of these, 20 (83%)
reported health outcomes only; the 4 (17%) remaining analyses
included also non-health outcomes. Thirty-two economic evalua-
tions (52%) included costs falling both within and outside the health
system. Of these, 21 (66%) reported only health outcomes; the 11
(34%) remaining analyses reported both health and non-health out-
comes. Figure 4 shows that numerous studies adopted different per-
spectives for the evaluation of costs and outcomes. Of note, almost
all analyses that measured only health outcomes but considered ex-
clusively costs falling outside the health system and ignored costs
(savings) for the health system were economic evaluations of fortifi-
cation strategies.
Out of the 27 evaluations of fortification and delivery strategies,
26 (96%) reported main results using a generic measure of health
(25 reported DALYs, 1 reported QALYs). By contrast, 16 (46%)
out of 35 evaluations of preventive and therapeutic interventions
reported results only in terms of impacts on specific health out-
comes. Overall, across the four topic areas, 16 (26%) evaluations
included non-health outcomes. Of these, 11 reported productivity
outcomes (i.e. impacts on income, wages, days of work, and vege-
table production) and 5 reported both productivity and education
outcomes (i.e. cognitive development, school performance, and
years of education) (see Supplementary Table S4 for further details).
To illustrate the challenge in interpreting studies with different
perspectives, in Box 1, we present a scenario describing the inter-
pretation of cost-effectiveness evidence to inform the development
of a national strategy to combat zinc deficiency.
Discussion
Main findings
We found that CEA was the most common analytical technique
employed for the economic evaluation of interventions that address
undernutrition across all settings. We observed differences in CEAs
of interventions delivered within the health sector (e.g. preventative
and therapeutic nutrition interventions) and outside the health sec-
tor (e.g. fortification strategies and other delivery platforms such as
price subsidies and conditional cash transfers). However, while we
observed clear differences in the categories of costs and outcomes
included, we cannot say whether this is due to the studies aiming to
inform different decision-makers. Most studies did not make clear
whether they aimed to inform decisions within the public sector,
and authors frequently failed to report the perspective adopted for
the evaluation or who pays for the intervention.
The choice of costs and outcomes considered in the studies was
also influenced by the degree of use of evaluation tools, such as the
widespread use of the Harvest-Plus approach (Stein et al., 2005) as
reference model to evaluate fortification strategies. We acknowledge
that the tool was developed with the aim of providing a common
framework for CEA of biofortification (Stein et al., 2007; 2008).
However, the reporting quality assessment in this review highlighted
that the tool was not accompanied by any reflection from authors
on appropriateness of perspective, model structure and outcomes
and costs included. By contrast, in studies where newly developed
models were employed, the appropriateness and justification of the
perspective adopted were discussed, reflecting on which costs to in-
clude in the model (Robberstad et al., 2004; Desmond et al., 2008;
Wilford et al., 2012; Chola et al., 2015).
In principle, the costs and outcomes in sectors outside the inter-
vention funder should not be ignored or that would risk prioritizing
interventions that impose costs on others, or conversely undervalu-
ing interventions. An impact on health is one of the core objectives
of nutrition interventions, and so it would seem relevant to consider
health outcomes. Impacts on healthcare resource use produce oppor-
tunity costs in terms of health production through alternative uses of
those resources. The boundaries for cost inclusion therefore should
align with the boundaries for outcome inclusion, driven by examin-
ation of the opportunity costs of the resources impacted by the inter-
vention. Outcomes and costs categories should reflect all the
relevant impacts of the intervention, and should be capable of ad-
equately inform the decision-makers. For example, economic evalu-
ations of zinc fortification interventions should consider costs
included in the health sector, particularly if interventions benefits
are measured using health outcomes.
Evaluations of preventive and therapeutic interventions frequent-
ly reported result only in terms of impacts on disease-specific health
outcomes, which might be less useful to inform comparisons across
topic areas. Most of the analyses of preventive and therapeutic inter-
ventions that reported generic outcome measures (e.g. DALYs)
included costs outside the health sector without considering the out-
comes that may be relevant outside the health sector, e.g. impacts on
productivity and earnings. Variations in DALYs averted were fre-
quently compared to costs falling within and outside the health sys-
tem accrued together. By contrast, most evaluations of fortification
strategies measured impacts of the intervention using DALYs but
considered costs falling outside the health system only. Because eval-
uations of preventive and therapeutic interventions typically
included also costs falling within the health system, resulting costs
per DALY will be systematically different from those of fortification
strategies, and not directly comparable.
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Box 1 Zinc case study
Alternative strategies to address zinc deficiency in China
In this example, we consider the use of published economic evidence to inform investment in addressing zinc deficiency in
China. Our review of the evidence (see Supplementary Table S5) identified a set of studies including the following evi-
dence-based policy options:
i. Preventative supplementation (Edejer et al., 2005; Ma et al., 2008; Bhutta et al., 2013; Fink and Heitner, 2014);
ii. Fortification of wheat (Wang et al., 2016), rice (Zhang et al., 2018), or combinations of different staple foods (Edejer et al., 2005;
Stein et al., 2007; Ma et al., 2008);
iii. Delivery platform based on social franchising (Bishai et al., 2015); and
iv. Therapeutic supplementation (Robberstad et al., 2004; Mejia et al., 2015; Shekar et al., 2016; Shillcutt et al., 2017).
For the sake of simplicity, we compare all strategies as independent and do not consider combinations not assessed within
the supporting studies. Cost-effectiveness estimates are summarized in Supplementary Table S6. We did not adjust the cur-
rencies to the same year, but we reported in the table the currency year and study year for each study.
Setting and location
The studies by Ma et al. (2008), Zhang et al. (2018) and Wang et al. (2016) were set in China. The study by Edejer et al.
(2005) was set in South-East Asia and sub-Saharan Africa. Fink et al. (2014) considered a representative low-income coun-
try. Bhutta et al. (2013) considered 34 countries, but not China. The study by Bishai et al. (2015) was set in Myanmar; Mejia
et al. (2015) in Colombia; and Robberstad et al. (2004) in the United Republic of Tanzania. The studies by Shillcutt et al.
(2017) and Stein et al. (2007) were set in India.
Preventive and fortification strategies
Ma et al. (2008) indicated that cost per DALY of fortification compared to doing nothing was lower than cost per DALY of
supplementation compared to doing nothing. However, comparators were not clearly specified and it was not clear
whether results were expressed as average or incremental cost effectiveness ratios (ICERs) compared to a scenario of
doing nothing. Furthermore, costs falling on the health system were not considered. By contrast, Edejer et al. (2005) did in-
clude healthcare costs and found that supplementation was more costly, but more effective than fortification, when com-
pared with a scenario of doing nothing. However, ICERs of supplementation compared to fortification were not reported1.
Wang et al. (2016) and Zhang et al. (2018) did not consider costs falling on the health system and reported incremental
costs of $226–594 and $311–4989 per DALY averted for fortification strategies vs doing nothing, respectively. These ICERs
are much higher compared to those reported in Edejer et al. (2005) ($14 and $55 per DALY averted in South East Asia and
Sub-Saharan Africa, respectively). Stein et al. (2007) adopted the same approach as Wang et al. (2016) and Zhang et al.
(2018) and found more favourable ICER of $0.73–7.31 per DALY averted for fortification vs doing nothing in India.
Fink et al. (2014) estimated an incremental cost of $606–1211 per DALY averted for preventive supplementation interventions
vs doing nothing. However, it was not clear whether health system costs were also included or not. Bhutta et al. (2013)
argued that scaling up preventive supplementation was cost effective in various countries but did not consider China.
Therapeutic interventions and delivery platforms
Bishai et al. (2015) estimated an incremental cost of $214 (societal perspective) or $339 (medical perspective) per DALY
averted for a delivery platform based on social franchising vs doing nothing. Both sets of results included healthcare costs,
and the flexibility in the perspectives considered for the evaluation could facilitate comparison across studies. However,
according to the authors, results may not be generalizable outside Myanmar because the organization promoting the pro-
gramme was fortunate to have a large provider network and donor support.
Mejia et al. (2015) found therapeutic zinc supplementation to be dominant (i.e. less costly and more effective in reducing chances
of diarrhoeal episodes and death) compared to standard treatment from the Colombian health system perspective. Shillcutt et al.
(2017) compared the same strategy to do nothing in India from a societal perspective. However, because results were expressed in
terms of cost per case averted, a comparative value of DALY to disease case would be required to perform a comparison with al-
ternative strategies. Robberstad et al. (2004) estimated an ICER of $40 per DALY averted for therapeutic supplementation compared
to standard treatment in the United Republic of Tanzania. However, the evaluation included both health system and non-health sys-
tem costs. Shekar et al. (2016) estimated health outcomes, healthcare and non-healthcare costs of scaling up therapeutic zinc sup-
plementation and found that was cost effective in various countries but did not consider China.
Summary
Caution is needed when using ICERs from reported studies, to avoid comparing results considering different cost categories.
Studies of interventions provided in different sectors often consider different costs and outcomes, with relevance determined
by the audience for the analysis. Similar studies in different settings give different ICERs, and ordering of fortification and
supplementation does not appear to be consistent across studies. Preventative strategy may have the highest ICER, but it is
unclear if this includes healthcare costs, which could lower the ICER. Therapeutic and delivery strategies may have the lowest
ICERs; however, there is no economic evidence for such strategies in China. In conclusion, studies are difficult to compare,
and it is challenging to use the available evidence to inform the identification of the optimal strategy to be adopted.
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Evaluations of preventative and therapeutic nutrition interven-
tions sometime included impacts on non-health outcomes such as
productivity and education. In contrast, evaluations of fortification
and delivery strategies frequently focused on impacts on health only,
and ignored non-health effects. Fortification and delivery strategies
might thus systematically omit relevant impacts of the intervention.
Studies that adopted a broader perspective frequently aggregated
all incremental costs and compared them to an incremental outcome
estimate. However, adding up monetary costs that fall on different
budgets may not adequately capture the opportunity costs (i.e. what
is forgone in order to accommodate the resources to provide new
services) (Sculpher et al., 2017). Given the different remits and for-
gone activities, an additional dollar commanded from the health sec-
tor displaces a different set of activities and outcomes to a dollar
commanded from the agricultural sector. By accruing all costs to-
gether, evaluations of preventative and therapeutic nutrition fre-
quently fail to distinguish impacts that fall on different sectors and
under the remit of different decision-makers (Walker et al., 2019).
Health and non-health effects and costs falling within and outside
the health system should be instead identified separately (Sculpher
et al., 2014).
Strengths and limitations
We did not include nutrition-sensitive interventions and so our re-
view is not inclusive of the full range of multisectoral nutrition-
sensitive approaches that has been recommended by Scaling Up
Nutrition and other nutrition advocacy groups [United Nations
Scaling Up Nutrition (SUN)/REACH Secretariat, 2016]. However,
even with the narrower focus on nutrition-specific interventions and
outcomes, we identified heterogeneity in the approach taken to eco-
nomic evaluation. Our review is not exhaustive, but identifying
more studies would be unlikely to alter this picture of heterogeneity
in costs and outcomes.
A similar systematic review by Gyles et al. in 2012 provided an
overview and summary of studies of nutrition interventions in which
health-related economic implications of the intervention have been
addressed, and considered a wider spectrum of strategies. Our study
focuses specifically on the context of nutrition interventions deliv-
ered in LMICs, considers the methodological aspects of each study
and provides an overview of more recent literature. However, find-
ings were similar, as the authors found that approaches and method-
ologies to calculate health-economic impacts of nutrition
interventions were sometimes ad hoc in nature and vary widely in
quality (Gyles et al., 2012).
Other economic evaluations of undernutrition have previously
been included but not distinguished, in broader systematic reviews
that focused on reproductive, maternal, newborn and child health
(Black et al., 2016) and on generic health interventions designed to
mitigate disease burden (Neumann et al., 2016). Other previous sys-
tematic reviews focused on the economic evaluation of specific inter-
vention strategies to address undernutrition, such as community
health worker interventions (Nkonki et al., 2017), food fortification
(Detzel and Wieser, 2015), and early childhood nutrition and devel-
opment interventions (Batura et al., 2015; Hurley et al., 2016).
However, previous reviews found results consistent with ours.
Similar issues were highlighted, such as: differences in methods for
standardizing costs (Black et al., 2016), lack of standardization in ef-
fectiveness measures across nutrition interventions conducted in dif-
ferent domains (Salam et al., 2015) and consequent difficulties to
compare the cost-effectiveness of interventions due to differences in
outcome measures (Batura et al., 2015). A move towards a common
outcome measure (e.g. cost-per-DALY averted) was advocated to fa-
cilitate the comparison of cost-effectiveness between studies and
contexts (Batura et al., 2015). Of note, on the one hand, the extent
to which the cost-per-DALY literature has addressed nutritional
deficiencies is much lower compared to other high burden disease
areas in LMICs (e.g. HIV/AIDS, tuberculosis, neglected tropical dis-
eases and malaria) (Neumann et al., 2016). On the other hand, a
general scarcity of studies on early childhood nutrition and develop-
ment interventions conducted from societal perspective was pointed
out (Batura et al., 2015), together with the need to consider broader
benefits than life saved specifically in the evaluation of nutrition
interventions (Black et al., 2016).
A standardized approach for the economic evaluation of nutri-
tion interventions may be difficult to establish due to the differences
in the methods traditionally adopted in the various sectors. Methods
for economic evaluation within the health sector have diverged from
methods typically employed outside the health sector, and analyses
are unlikely to be equivalent and may yield different resource alloca-
tion decisions (Bala et al., 2002). However, better transparency
about perspective adopted, outcomes and costs considered and
assumptions employed would facilitate the comparison across stud-
ies from different areas, even if based on different approaches.
We acknowledge the difficulties and limitations of using check-
lists to evaluate the quality of such a heterogenous set of studies
(Wijnen et al., 2016). Economic evaluations involved strategies that
may be enacted by different decision-makers from different settings
and therefore might need to accommodate needs and preferences of
different agencies. However, we showed that systematic differences
and trends by type of intervention are not connected to countries
and settings. Our research strategy included only studies published
in peer-reviewed journals, in English. Grey literature was not
investigated.
Conclusion
Alternative strategies are available to address the same nutrition
deficiencies. Comparing interventions across various topic areas
becomes thus fundamental to assist decision-makers (such as the
Ministry of Health or the Ministry of Agriculture) in prioritizing al-
ternative nutrition interventions. In this review, we highlighted
trends and systematic differences in the approach to the economic
evaluation of interventions and strategies implemented within and
across different sectors of the economy. Furthermore, we illustrated
how inconsistencies in the approaches can undermine the ability to
compare across studies and have important consequences for
decision-making. We showed how the use of ‘off-the-shelf’ models
and tools can conceal what outcomes, costs and value judgements
are adopted in the economic evaluation.
We echo the recommendation by Gyles et al. (2012) who called
for the development of an encompassing economic framework that
would allow for a uniform and complete measurement of the eco-
nomic costs and benefits borne by all stakeholders. For example,
comparison across studies would be facilitated by the compilation of
impact inventories that distinguish impacts on the different sectors
and dimensions, as recommended by the Second panel on CEA
(Sanders et al., 2016; Walker et al., 2019). Furthermore, following
reporting standards as indicated in various reference cases
(Wilkinson et al., 2016; Vassall et al., 2017; Robinson et al., 2019)
would help to promote consistency and improve the quality of fu-
ture studies, thus facilitating their comparability and decision-
making.
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Notes
1. This is because the study compared various strategies and com-
binations of treatments addressing also deficiencies other than
zinc, and these specific zinc interventions were dominated by
other alternative interventions. However, with available data,
ICERs could be calculated.
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